rss
Br J Ophthalmol 88:982-987 doi:10.1136/bjo.2003.039131
  • Value based ophthalmology

Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration

Table 5

 Comparison of cost utility output from different published modelling approaches with different visual acuity (VA) starting points

Model Details Cost/QALY
Hopley et al (this study)
Model 1 Reasonable VA, continuous PDT, 7 year model 31 607
Model 2 Poor VA, continuous PDT, 7 year model 63 214
Sharma et al11
Base case 1 Reasonable VA, 2 years PDT, 2 year model 56 716
Base case 2 Poor VA, 2 years PDT, 2 year model 113 786
Meads et al12
Model 1 year model 137 138

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.